Clinical Trial: Genentech is Now Enrolling Phase I Study to Test DLK Inhibitor

Genentech, a member of the Roche group, has initiated a Phase I clinical study evaluating GDC-0134, an oral investigational medicine designed to block dual leucine zipper kinase (DLK), for the potential treatment of ALS. The trial is enrolling now in sites across the United States.

Continue reading Clinical Trial: Genentech is Now Enrolling Phase I Study to Test DLK Inhibitor

Advocacy Day 2017 Highlights

On May 14- 16 more than 600 advocates took part in a very successful National ALS Advocacy Conference here in Washington, DC. Of the 600 advocates, 130 were people living with ALS. On Sunday and Monday, national experts and officials briefed participants on The ALS Association priorities and other “hot topics” that they might encounter in their congressional meetings and Chapter Executives prepared their state delegations for Hill meetings.

Continue reading Advocacy Day 2017 Highlights

“Extraordinary” Collaboration Brings Together Project MinE, Answer ALS and the New York Genome Center

 

The ALS Association is proud to announce three large research organizations — Project MinE USA, Answer ALS and the New York Genome Center (NYGC) — will be working collaboratively toward their mission for treatments and a cure for ALS. These global collaborative projects, supported by The ALS Association through ALS Ice Bucket Challenge donations, will share genome sequencing information and research expertise to move efforts forward more rapidly and efficiently. Read more to learn about how global partnerships advance ALS research.

Continue reading “Extraordinary” Collaboration Brings Together Project MinE, Answer ALS and the New York Genome Center

New ALS Review on Newsstands: Unlocking the Mystery of ALS

The June issue of Scientific American on newsstands this month features, “Unlocking the Mystery of ALS,” which details the significant advances of ALS research over the years. The authors, Drs. Leonard Petrucelli at the Mayo Clinic in Jacksonville and Aaron Gitler at the Stanford University School of Medicine, thoughtfully explained the complicated science behind ALS, while weaving a story of its breakthroughs and the steps needed to get to the ultimate goal – an end to ALS. They covered genetic discovery, starting with SOD1 in 1993 through today, which has sky rocketed in recent years, largely in part due to the donations dedicated to ALS research through the ALS Ice Bucket Challenge. Exciting therapeutic advances were explained, like a gene silencing technique, called antisense oligonucleotide (ASO) therapy, a way to track disease progression and improve diagnosis, called biomarkers, and targeting the support cells of the brain, called glia, and more were all described in a clear way.

Continue reading New ALS Review on Newsstands: Unlocking the Mystery of ALS

Concerns About President Trump’s Proposed Budget Cuts

Last week, President Trump submitted his budget request to Congress. Included in the proposal are changes to funding for Medicaid, cuts to Social Security Disability Insurance (SSDI), cuts to the National Institutes of Health (NIH) and the complete defunding of the National ALS Registry at the Centers for Disease Control (CDC). The ALS Association is very concerned that these proposals will negatively impact people affected by ALS and will slow down the progress we have made in research for treatments and a cure. We do not believe this is a partisan issue – Members of Congress on both sides of the aisle have expressed concerns about the cuts contained in the President’s budget.

Continue reading Concerns About President Trump’s Proposed Budget Cuts

Q & A with Stephen Winthrop, Chair, ALS Association National Board of Trustees

Today, we sit down with Stephen Winthrop, our newly elected Chair of The ALS Association Board of Trustees to hear his thoughts on the fight against ALS and the role of The ALS Association in that fight. Stephen first joined the Association as a Trustee in 2015. He brings his expertise in fundraising, financial management, grant writing and information management services for non-profit organizations gained from a career in management consulting. He was diagnosed with ALS in November 2013 and immediately focused his energy on the fight against ALS. We are proud to be led by such a great leader and tireless ALS advocate.

Continue reading Q & A with Stephen Winthrop, Chair, ALS Association National Board of Trustees

ALS Films to Watch

There are many ways, both big and small, to raise ALS awareness. Some people have used their filmmaking or public speaking talents to craft compelling stories of those living with this disease. From TED talks to award-winning documentaries, these videos inspire, educate, challenge and entertain viewers, while celebrating the lives of people with ALS and the contributions they have made.

Continue reading ALS Films to Watch